Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Open-label, Tolerability and Efficacy Study of Civamide Nasal Solution, 0.01%, in Patients With Dry Eye Syndrome

NCT02116244 is registered in ClinicalTrials.gov with Winston Laboratories as lead sponsor.

NCT NCT02116244
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02116244 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Open-label, Tolerability and Efficacy Study of Civamide Nasal Solution, 0.01%, in Patients With Dry Eye Syndrome
Lead sponsor
Winston Laboratories
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2014
Completion date
September 30, 2015
Enrollment
31 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye